期刊
JOURNAL OF IMMUNOLOGY
卷 185, 期 7, 页码 4179-4188出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1001956
关键词
-
类别
资金
- Immune System Therapeutics Ltd, Australia
- National Health and Medical Research Council of Australia [ID365209]
- Victorian Operational Infrastructure Support Program
Free kappa L chains (F kappa LCs) are expressed on the surface of myeloma cells and are being assessed as a therapeutic target for the treatment of multiple myeloma. Despite its clinical potential, the mechanism by which F kappa LCs interact with membranes remains unresolved. In this study, we show that F kappa LCs associate with sphingomyelin on the plasma membrane of myeloma cells. Moreover, membrane-bound F kappa LCs are aggregated, suggesting that aggregation is required for intercalation with membranes. Finally, we propose a model where the binding of F kappa LCs with sphingomyelin on secretory vesicle membranes is stabilized by self-aggregation, with aggregated F kappa LCs exposed on the plasma membrane after exocytosis. Although it is well known that protein aggregates bind membranes, this is only the second example of an aggregate being found on the surface of cells that also secrete the protein in its native form. We postulate that many other aggregation-prone proteins may associate with cell membranes by similar mechanisms. The Journal of Immunology, 2010, 185: 4179-4188.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据